Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
Top Cited Papers
- 1 January 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (1), 120-122
- https://doi.org/10.1016/j.amjcard.2004.08.076
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The effect of gemfibrozil on the pharmacokinetics of rosuvastatinClinical Pharmacology & Therapeutics, 2004
- Gemfibrozil considerably increases the plasma concentrations of rosiglitazoneDiabetologia, 2003
- CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinideBritish Journal of Clinical Pharmacology, 2003
- Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearanceClinical Pharmacology & Therapeutics, 2003
- Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinideDiabetologia, 2003
- Gemfibrozil Inhibits CYP2C8-Mediated Cerivastatin Metabolism in Human Liver MicrosomesDrug Metabolism and Disposition, 2002
- Gemfibrozil greatly increases plasma concentrations of cerivastatinClinical Pharmacology & Therapeutics, 2002
- Effects of fibrates on metabolism of statins in human hepatocytes.Drug Metabolism and Disposition, 2002
- Mechanistic Studies on Metabolic Interactions between Gemfibrozil and StatinsJournal of Pharmacology and Experimental Therapeutics, 2002
- Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazoneBritish Journal of Clinical Pharmacology, 1999